Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Lian Jiang
Dao-yuan Wang
Zhi-hua Zhu
Liang-fa Tang
Xin-heng Hou
Hong-da Zhao
Zheng Xie
Dan-feng Wang
机构：
[1] Nantong University,Department of Respiratory Medicine, Jiangyin People’s Hospital
[2] Sun Yat-sen University,Department of Thoracic Oncology, State Key Laboratory of Oncology in South China, Cancer Center, Lung Cancer Research Center
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Advanced non-small cell lung cancer; Docetaxel; Carboplatin; Weekly;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：449 / 453
页数：4
相关论文
共 50 条
  • [21] Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II study
    Pectasides, D
    Visvikis, A
    Kouloubinis, A
    Glotsos, J
    Bountouroglou, N
    Karvounis, N
    Ziras, N
    Athanassiou, A
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (09) : 1194 - 1200
  • [22] Phase II trial of docetaxel and carboplatin in the treatment of advanced non-small cell lung cancer
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1076 - 1076
  • [23] A phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer
    Zarogoulidis, K
    Kontakiotis, T
    Hatziapostolou, P
    Fachantidou, E
    Delis, D
    Goutsikas, J
    Constantinidis, TC
    Athanasiadis, A
    Patakas, D
    [J]. LUNG CANCER, 2001, 32 (03) : 281 - 287
  • [24] Phase II study of the combination chemotherapy with weekly carboplatin and gemcitabine in advanced non-small cell lung cancer
    Mori, K.
    Kamiyama, Y.
    Kasai, H.
    Kodama, T.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 524 - 524
  • [25] Phase I/II study of carboplatin and weekly paclitaxel for advanced non-small cell lung cancer.
    Ohashi, N
    Arita, KI
    Daga, H
    Mito, A
    Nishino, R
    Moritani, C
    Nakamura, K
    Daido, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 687S - 687S
  • [26] A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer
    Dragnev, Konstantin H.
    Whyman, Jeremy D.
    Hahn, Cynthia K.
    Kebbekus, Peter E.
    Kokko, Sarah F.
    Bhatt, Sunil M.
    Rigas, James R.
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5531 - 5537
  • [27] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] A PHASE I/II STUDY OF BEXAROTENE WITH WEEKLY PACLITAXEL AND CARBOPLATIN FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Whyman, Jeremy D.
    Kebbekus, Peter E.
    Fink, Sarah K.
    Rigas, James R.
    Dragnev, Konstantin H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S883 - S883
  • [29] Phase I trial of bi-weekly docetaxel combined with carboplatin for patients with non-small cell lung cancer.
    Inoue, A
    Ishida, T
    Saijo, Y
    Maemondo, M
    Suzuki, T
    Kimura, Y
    Ohkouchi, S
    Nukiwa, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 676S - 676S
  • [30] A phase I study of weekly docetaxel and cisplatin in advanced non-small cell lung cancer
    Sato, K
    Tsuchiya, S
    Minato, K
    Takei, Y
    Watanabe, S
    Saitoh, R
    Mori, M
    [J]. LUNG CANCER, 2001, 33 (01) : 69 - 73
12345